Myriad Women’s Health offers seamless support and services to make it easy to integrate genetic screening into your practice. The Myriad Foresight Carrier Screen is systematically designed to maximize the detection of at-risk couples for a pregnancy affected by inherited conditions. Screening for genetic abnormalities: Trisomy 21 (Down syndrome) Trisomy 18 (Edwards syndrome) Trisomy 13 (Patau syndrome) Triploidy Monosomy X (Turner. Myriad Women’s Health pioneered expanded carrier screening to empower patients with advanced knowledge that can make a difference in health outcomes.
Myriad Foresight Carrier Screen (Previously known as Counsly) Requiring only maternal blood drawn from the mother, iGene® is based on Next Generation Sequencing technology that analyses blood samples via a Whole Genome Sequencing approach. IGene® is a non-invasive prenatal test that can detect chromosomal abnormalities, including trisomy aneuploidies, sex chromosome aneuploidies, and deletion syndromes, while providing information on foetal sex, if required. Non-Invasive Prenatal Testing (“NIPT”) is a screening test that analyses foetal DNA in a mother’s blood to screen for foetal chromosomal abnormalities. Panorama analyzes baby's (placental) DNA through a simple blood draw from the mother’s arm.Īn essential step in providing peace of mind, prenatal testing ensures that pregnant mothers stay informed about the status of their pregnancy. Panorama is a market-leading noninvasive prenatal screening test (NIPT) that reveals your baby’s risk for genetic disorders as early as nine weeks.
0 kommentar(er)
